Atricure Inc. buy UBS Group AG
Start price
16.02.24
/
50%
€28.89
Target price
16.02.25
€53.79
Performance (%)
-
End price
17.02.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -2.432% | -2.432% | -53.411% |
| iShares Core DAX® | 2.709% | 3.467% | 27.799% |
| iShares Nasdaq 100 | 0.867% | 5.198% | 18.207% |
| iShares Nikkei 225® | 3.135% | 9.423% | 11.810% |
| iShares S&P 500 | 0.886% | 3.586% | 12.096% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $57.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten